Germany-based medical technology company Microstim secured series A funding worth €1.5m ($2m) on Thursday from a pool of Germany-based investors including federal state fund Technologiefonds MV, the corporate-backed venture capital fund High-Tech Gründerfonds and Fides Finanz-Invest, a division of the Jasika property group. High-Tech Gründerfonds previously supplied seed financing to Microstim in February 2009, investing…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
